Replying to @Brucekoala post 71022125 above:
What's slightly harder to fathom is that fully diluted IMU SOI is now approximately 8.2 billion. This means that every 2 cent rise in the IMU share price is effectively adding a new RAC to their market capitalisation (at the current RAC share price anyway).
Have Imugene effectively added 3 drugs with the potential of Bisantrene to their portfolio in the last 2 weeks (and bear in mind it was closer to 6 RACs in additional market cap when they recently hit 15 cents)?
If we assume that Bisantrene isn't a dud and management are able to pull it together (this is the reason we're here after all), to me it means there is currently a huge mispricing in the market between IMU and RAC... long term either IMU needs to fall or RAC needs to rise to correct this.
Ann: Letter to Shareholders, Notice of AGM & Proxy Form, page-65
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
-0.075(4.02%) |
Mkt cap ! $304.8M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.86 | $1.76 | $348.2K | 192.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5612 | $1.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 3567 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.78 |
Change
-0.075 ( 5.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.81 | $1.86 | $1.76 | 27553 | ||
| Last updated 15.55pm 14/06/2024 ? | |||||
| RAC (ASX) Chart |